The New York Times @nytimes
The Alzheimer’s drug, lecanemab, slowed cognitive decline a bit but also caused risks for patients and should be studied further, new data shows. https://t.co/rwNnawwqYE — PolitiTweet.org
Created
Wed Nov 30 01:40:02 +0000 2022
Likes
262
Retweets
83
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The New York Times @nytimes
The Alzheimer’s drug, lecanemab, slowed cognitive decline a bit but also caused risks for patients and should be studied further, new data shows. https://t.co/rwNnawwqYE — PolitiTweet.org